Related Experiment Video
Updated: Aug 18, 2026

miRNA Expression Analyses in Prostate Cancer Clinical Tissues
Published on: September 8, 2015
ILK as a potential marker gene to ascertain specific adenocarcinoma cell mRNA isolation from frozen prostate biopsy
Nelly Kieffer1, Martine Schmitz, Sébastien Plançon
1Laboratoire de Biologie et Physiologie Intégrée LBPI, Université du Luxembourg, L-1511 Luxembourg, Luxembourg. kieffer@cu.lu
Abstract:
A major technical challenge related to gene expression profiling of tissue samples is the difficulty of procuring selected cell populations from tissues that by nature are heterogeneous, such as prostate tissue. In this study we have examined the expression of integrin-linked kinase (ILK) mRNA in prostate adenocarcinoma cells versus normal prostate epithelial cells in order to determine whether ILK could be used as a reference marker gene for prostate adenocarcinoma cell mRNA isolation. Using laser microdissection (LMD) technology and real-time PCR, together with immunohistochemistry, we have analyzed ILK mRNA expression in epithelial cells isolated from frozen prostate biopsy specimens as well as 4 prostate cell lines (RWPE-1, LNCaP, PC-3 and DU 145) and correlated ILK mRNA expression with ILK protein expression. We demonstrate that quantitative upregulation of ILK mRNA expression in prostate epithelial cells derived from prostate tissue correlated with ILK protein expression and with the histopathology diagnosis of prostate adenocarcinoma. We further show that the level of ILK overexpression was directly influenced by the method used to isolate prostate adenocarcinoma cells (bulk tissue versus LMD dissected cells). These data provide evidence that ILK mRNA is quantitatively upregulated in prostate adenocarcinoma cells versus normal epithelial cells and is therefore a useful internal reference gene marker to evaluate the quality of prostate adenocarcinoma cell derived mRNA used for large scale prostate cancer cDNA gene profiling.
Insights
Integrin-linked kinase (ILK) mRNA is upregulated in prostate adenocarcinoma cells compared to normal cells. This finding supports ILK as a reliable reference gene for prostate cancer gene expression profiling.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Gene expression profiling of heterogeneous tissues like prostate is challenging.
- Accurate isolation of specific cell populations is crucial for reliable results.
Purpose of the Study:
- To investigate integrin-linked kinase (ILK) mRNA expression in prostate adenocarcinoma versus normal epithelial cells.
- To determine if ILK can serve as a reference marker gene for prostate cancer research.
Main Methods:
- Laser microdissection (LMD) and real-time PCR were used to analyze ILK mRNA expression.
- Immunohistochemistry was employed to assess ILK protein levels.
- Analysis included prostate biopsy specimens and cell lines (RWPE-1, LNCaP, PC-3, DU 145).
Main Results:
- ILK mRNA expression was quantitatively upregulated in prostate adenocarcinoma cells.
- Increased ILK mRNA correlated with ILK protein expression and cancer diagnosis.
- Cell isolation methods (bulk vs. LMD) influenced ILK overexpression levels.
Conclusions:
- ILK mRNA is a validated marker for upregulation in prostate adenocarcinoma.
- ILK serves as a useful internal reference gene for assessing mRNA quality in prostate cancer studies.
- This facilitates accurate gene profiling for large-scale prostate cancer research.
More Related Videos
13:19Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
Published on: November 2, 2013
12:13Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients
Published on: November 19, 2019